921940-82-1 Usage
Uses
Used in Pharmaceutical Synthesis:
Ethyl 2-(5-((tert-butoxycarbonyl)amino)pyridin-2-yl)acetate is used as an intermediate in the synthesis of various pharmaceuticals for its ability to facilitate the creation of complex organic molecules. The Boc protecting group allows for selective reactions to occur, ensuring the integrity of the molecule during the synthesis process.
Used in Organic Chemistry Research:
In the field of organic chemistry, ethyl 2-(5-((tert-butoxycarbonyl)amino)pyridin-2-yl)acetate is employed as a research compound to explore novel reactions and mechanisms. Its unique structure allows chemists to investigate the reactivity of pyridine derivatives and the influence of the Boc group on reaction outcomes.
Used in Drug Development:
Ethyl 2-(5-((tert-butoxycarbonyl)amino)pyridin-2-yl)acetate is utilized in drug development as a key component in the synthesis of potential therapeutic agents. Its presence in the molecular structure can impart specific biological activities, making it a valuable building block in the creation of new drugs.
Used in Chemical Process Development:
In the chemical process development industry, ethyl 2-(5-((tert-butoxycarbonyl)amino)pyridin-2-yl)acetate is used to optimize and refine the synthesis of complex organic compounds. Its versatility and the presence of the Boc protecting group make it an ideal candidate for process improvement and scale-up efforts.
Overall, ethyl 2-(5-((tert-butoxycarbonyl)amino)pyridin-2-yl)acetate is a versatile and valuable chemical compound with applications spanning across various industries, including pharmaceuticals, organic chemistry research, drug development, and chemical process development. Its unique structure and functional groups contribute to its wide range of uses and importance in the synthesis and development of new compounds.
Check Digit Verification of cas no
The CAS Registry Mumber 921940-82-1 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 9,2,1,9,4 and 0 respectively; the second part has 2 digits, 8 and 2 respectively.
Calculate Digit Verification of CAS Registry Number 921940-82:
(8*9)+(7*2)+(6*1)+(5*9)+(4*4)+(3*0)+(2*8)+(1*2)=171
171 % 10 = 1
So 921940-82-1 is a valid CAS Registry Number.
921940-82-1Relevant academic research and scientific papers
Making method of t-butyloxycarboryl-3-(hydroxymethyl)-[1,2,3]triazole[1,5-a]piperidine-6-amide
-
Paragraph 0007; 0010, (2017/10/13)
The invention relates to a synthesis method of t-butyloxycarboryl-3-(hydroxymethyl)-[1,2,3]triazole[1,5-a]piperidine-6-amide. The technical problem that a suitable industrial synthesis method does not exist at present is mainly solved. The synthesis method is divided into the following seven steps of firstly making (2-chloro-5-nitropyridine) and t-butyl ethyl malonate react in a solvent tetrahydrofuran under the action of NaH to obtain a compound 2; obtaining a compound 3 from the compound 2 under the action of trifluoroacetic acid; afterwards, subjecting the compound 3 to a hydrogenation reaction under the catalysis of palladium carbon to obtain a compound 4; carrying out t-butyloxycarboryl protection on the compound 4 to obtain a compound 5; making the compound 5 act with p-ABSA (p-Acetamidobenzenesulfonyl Azide) under the action of DBU (1,8-Diazabicyclo[5,4,0]undec-7-ene) to obtain a compound 6; reducing the compound 6 in the tetrahydrofuran by lithium aluminium tetrahydride to obtain a compound 7; subjecting the compound 7 to catalytic hydrogenation under the catalysis of wet palladium carbon to obtain a final compound 8.
QUINOLONE DERIVATIVES AS FIBROBLAST GROWTH FACTOR INHIBITORS
-
Page/Page column 83, (2014/12/09)
Compounds of formula (Ι') that are Fibroblast Growth Factor Inhibitors (FGFR) and are therefore useful for the treatment of diseases treatable by inhibition of FGFR are disclosed. Also disclosed are pharmaceutical compositions containing such compounds and processes for preparing such compounds.
INDAZOLECARBOXAMIDE DERIVATIVES AS 5HT4 RECEPTOR AGONISTS
-
Page/Page column 25, (2008/06/13)
This invention relates to compounds of the formula (I): or pharmaceutically acceptable salts thereof, wherein: R1, R2, R3, A and m are each as described herein and compositions containing such compounds and the use of such
